IL62318A - 2,4-diamino-5-sulfamoylbenzene sulfonic acids,process for their manufacture and drugs containing same - Google Patents

2,4-diamino-5-sulfamoylbenzene sulfonic acids,process for their manufacture and drugs containing same

Info

Publication number
IL62318A
IL62318A IL62318A IL6231881A IL62318A IL 62318 A IL62318 A IL 62318A IL 62318 A IL62318 A IL 62318A IL 6231881 A IL6231881 A IL 6231881A IL 62318 A IL62318 A IL 62318A
Authority
IL
Israel
Prior art keywords
sulfamoylbenzene
diamino
manufacture
sulfonic acids
containing same
Prior art date
Application number
IL62318A
Other languages
English (en)
Other versions
IL62318A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL62318A0 publication Critical patent/IL62318A0/xx
Publication of IL62318A publication Critical patent/IL62318A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL62318A 1980-03-11 1981-03-09 2,4-diamino-5-sulfamoylbenzene sulfonic acids,process for their manufacture and drugs containing same IL62318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803009229 DE3009229A1 (de) 1980-03-11 1980-03-11 2,4-diamino-5-sulfamoylbenzolsulfosaeuren und verfahen zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IL62318A0 IL62318A0 (en) 1981-05-20
IL62318A true IL62318A (en) 1985-02-28

Family

ID=6096821

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62318A IL62318A (en) 1980-03-11 1981-03-09 2,4-diamino-5-sulfamoylbenzene sulfonic acids,process for their manufacture and drugs containing same

Country Status (14)

Country Link
US (1) US4341773A (es)
EP (1) EP0035723B1 (es)
JP (1) JPS56142255A (es)
AR (1) AR227777A1 (es)
AT (1) ATE4899T1 (es)
AU (1) AU537230B2 (es)
CA (1) CA1155450A (es)
DE (2) DE3009229A1 (es)
DK (1) DK109081A (es)
ES (1) ES500103A0 (es)
FI (1) FI69459C (es)
HU (1) HU187322B (es)
IL (1) IL62318A (es)
ZA (1) ZA811573B (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE768706A (fr) * 1970-06-18 1971-12-20 Leo Pharm Prod Ltd Nouveaux acides sulfamoylbenzoiques
DE2232457A1 (de) * 1972-07-01 1974-01-10 Boehringer Mannheim Gmbh Neue 3-alkyl-4-sulfamoylanilinderivate
DE2334973A1 (de) * 1973-07-10 1975-01-23 Boehringer Mannheim Gmbh Neue biphenyl-derivate
DE2453548A1 (de) * 1973-09-07 1976-03-18 Hoechst Ag Substituierte aminobenzoesaeurederivate und verfahren zu ihrer herstellung
DE2406972C3 (de) * 1974-02-14 1979-07-19 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
DE2718871C3 (de) * 1977-04-28 1980-07-17 Hoechst Ag, 6000 Frankfurt N-(2-Furylmethyl)-5-sulfamoylorthanilsäuren und deren physiologisch verträgliche Salze und Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Oedemkrankheiten und Bluthochdruck

Also Published As

Publication number Publication date
US4341773A (en) 1982-07-27
ZA811573B (en) 1982-04-28
AU537230B2 (en) 1984-06-14
FI810724L (fi) 1981-09-12
IL62318A0 (en) 1981-05-20
DE3009229A1 (de) 1981-10-15
EP0035723B1 (de) 1983-10-05
JPS56142255A (en) 1981-11-06
AU6819681A (en) 1981-09-17
ES8201996A1 (es) 1982-01-01
ES500103A0 (es) 1982-01-01
ATE4899T1 (de) 1983-10-15
FI69459C (fi) 1986-02-10
EP0035723A1 (de) 1981-09-16
DK109081A (da) 1981-09-12
FI69459B (fi) 1985-10-31
AR227777A1 (es) 1982-12-15
CA1155450A (en) 1983-10-18
HU187322B (en) 1985-12-28
DE3161077D1 (en) 1983-11-10

Similar Documents

Publication Publication Date Title
MY8700363A (en) 7-amino-1-gyclopropyl-4-oxo-1, 4-dihydronaphthyridine-3-carboxylic acids, process for their preparation and medicaments containing these compounds
DE2962568D1 (en) Antiinflammatory 4,5-diaryl-2-nitroimidazoles, method for their preparation and pharmaceutical composition containing them
ZA814606B (en) New benzisoselenazolones process for producing the same and pharmaceutical preparations containing the same
PT73388B (en) Process for preparing antiinflammatory 4,5-diaryl-alfa-poly- fluoroalkyl-1h-imidazole-2-methanamides and pharmaceutical compositions containing the same
DE3172006D1 (en) Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof
DE3168902D1 (en) Epoxy-cycloalkylalkanecarboxylic acids, process for their preparation, their use and medicaments containing them
ZA821637B (en) Oxazaphosphorin-4-thio-alkanesulfonic acids, neutral salts thereof, processes for the production thereof and pharmaceutical preparations containing them
DE3166656D1 (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives, process for their preparation and medicines containing them
IL61371A (en) Medicaments containing phenyloxoalkanoic acids,some new such acids and processes for their preparation
EP0110397A3 (en) Polyprenyl compound, process for the production thereof and drug containing the same
MY8600270A (en) Phenylaminothiophenacetic acids, processes for their preparation and medicaments containing them
DE3160780D1 (en) 2,3-dichloro-2-trifluoromethyl-1,1,1,3,4,4,5,5,5-nonafluoropentane and process for its preparation
DE2860928D1 (en) 2,4-diamino-5-benzyl-pyrimidines, process for their preparation and medicines containing them
IL59760A0 (en) 7-oxo-4-thia-1-aza-bicyclo(3,2,0)-heptane-2-carboxylic acid derivatives,and process for their preparation
DE3163490D1 (en) 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, process for their preparation and pharmaceutical compositions containing them
DE3165498D1 (en) Process for the preparation of erythromycylamine 11,12-carbonate
ZA815621B (en) Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them
IL63247A0 (en) Process for the manufacture of 2,6-dichlorobenzoxazole and 2,6 dichlorobenzthiazole
EP0042092A3 (en) 1,4-dihydropyridine-4-carboxamides, process for preparing them, their use as medicines and preparation thereof
IL62318A (en) 2,4-diamino-5-sulfamoylbenzene sulfonic acids,process for their manufacture and drugs containing same
DE3160364D1 (en) 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol, a process for producing same and a pharmaceutical composition
DE2967433D1 (en) 3-amino-cardenolides, process for their preparation and medicines containing them
DE3160037D1 (en) Process for the preparation of 2,4,6-trifluorotriazine-(1,3,5)
DE3160222D1 (en) Process for the preparation of 2,6-xylidine
DE2960521D1 (en) 2-amino-3a,4,5,6-tetrahydroperimidine derivatives, medicaments containing them and process for their preparation